secwatch.observer — SEC 8-K summary
======================================

Issuer:     CUMBERLAND PHARMACEUTICALS INC (CPIX)
CIK:        0001087294
Form:       8-K
Filed at:   2026-06-25T21:00:32+00:00
Accession:  0001087294-26-000053
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve sale of Cumberland's FDA-approved products to Apotex
-------------------------------------------------------------------------

- Shareholders voted 10,492,455 For (99.84% of votes cast), 15,904 Against, 1,267 Abstain.
- Transaction involves sale of FDA-approved commercial products and related assets to Apotex Inc.
- Approval allows Cumberland to integrate products with Apotex's U.S. branded business per April 22, 2026 APA.
- Special meeting held June 24, 2026; quorum of 70.14% of outstanding shares (10,509,626 shares represented).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1087294/000108729426000053/0001087294-26-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1087294/000108729426000053/cpix-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001087294-26-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer